Works by Razis, Evangelia

Results: 42
    1
    2
    3

    Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group.

    Published in:
    Cancers, 2021, v. 13, n. 18, p. 4621, doi. 10.3390/cancers13184621
    By:
    • Linardou, Helena;
    • Spanakis, Nikolaos;
    • Koliou, Georgia-Angeliki;
    • Christopoulou, Athina;
    • Karageorgopoulou, Sofia;
    • Alevra, Nephely;
    • Vagionas, Anastasios;
    • Tsoukalas, Nikolaos;
    • Sgourou, Stavroula;
    • Fountzilas, Elena;
    • Sgouros, Joseph;
    • Razis, Evangelia;
    • Chatzokou, Dimitra;
    • Lampaki, Sofia;
    • Res, Eleni;
    • Saridaki, Zacharenia;
    • Mountzios, Giannis;
    • Saroglou, George;
    • Fountzilas, George
    Publication type:
    Article
    4

    Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.

    Published in:
    2020
    By:
    • Koutras, Angelos;
    • Zagouri, Flora;
    • Koliou, Georgia-Angeliki;
    • Psoma, Elizabeth;
    • Chryssogonidis, Ioannis;
    • Lazaridis, Georgios;
    • Tryfonopoulos, Dimitrios;
    • Kotsakis, Athanasios;
    • Res, Eleni;
    • Kentepozidis, Nikolaos K.;
    • Razis, Evangelia;
    • Psyrri, Amanda;
    • Koumakis, Georgios;
    • Kalofonos, Haralabos P.;
    • Dimopoulos, Meletios A.;
    • Fountzilas, George
    Publication type:
    journal article
    5

    Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

    Published in:
    Journal of Neuro-Oncology, 2017, v. 134, n. 2, p. 443, doi. 10.1007/s11060-017-2548-z
    By:
    • Christodoulou, Christos;
    • Kalogera-Fountzila, Anna;
    • Karavasilis, Vasilios;
    • Kouvatseas, George;
    • Papandreou, Christos;
    • Samantas, Epaminontas;
    • Varaki, Kalliopi;
    • Papadopoulos, Georgios;
    • Bobos, Mattheos;
    • Rallis, Grigorios;
    • Razis, Evangelia;
    • Goudopoulou, Athina;
    • Kalogeras, Konstantine;
    • Syrigos, Konstantinos;
    • Fountzilas, George
    Publication type:
    Article
    6

    p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab.

    Published in:
    Pathology & Oncology Research, 2015, v. 21, n. 2, p. 273, doi. 10.1007/s12253-014-9818-2
    By:
    • Pavlakis, Kitty;
    • Bobos, Mattheos;
    • Batistatou, Anna;
    • Kotoula, Vassiliki;
    • Eleftheraki, Anastasia;
    • Stofas, Anastasios;
    • Timotheadou, Eleni;
    • Pentheroudakis, George;
    • Psyrri, Amanda;
    • Koutras, Angelos;
    • Pectasides, Dimitrios;
    • Papakostas, Pavlos;
    • Razis, Evangelia;
    • Christodoulou, Christos;
    • Kalogeras, Konstantine;
    • Fountzilas, George
    Publication type:
    Article
    7
    8

    Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 7, p. 1200, doi. 10.1093/neuonc/noad038
    By:
    • Weller, Michael;
    • Rhun, Emilie Le;
    • Bent, Martin Van den;
    • Chang, Susan M;
    • Cloughesy, Timothy F;
    • Goldbrunner, Roland;
    • Hong, Yong-Kil;
    • Jalali, Rakesh;
    • Jenkinson, Michael D;
    • Minniti, Giuseppe;
    • Nagane, Motoo;
    • Razis, Evangelia;
    • Roth, Patrick;
    • Rudà, Roberta;
    • Tabatabai, Ghazaleh;
    • Wen, Patrick Y;
    • Short, Susan C;
    • Preusser, Matthias
    Publication type:
    Article
    9
    10
    11
    12
    13

    Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.

    Published in:
    2001
    By:
    • Razis, Evangelia;
    • Dimopoulos, Athanassios-Meletios;
    • Bafaloukos, Dimitris;
    • Papadimitriou, Christos;
    • Kalogera-Fountzila, Anna;
    • Kalofonos, Haralambos;
    • Briassoulis, Evangelos;
    • Samantas, Epaminontas;
    • Keramopoulos, Antonios;
    • Pavlidis, Nicholas;
    • Kosmidis, Paris;
    • Fountzilas, George;
    • Razis, E;
    • Dimopoulos, A M;
    • Bafaloukos, D;
    • Papadimitriou, C;
    • Kalogera-Fountzila, A;
    • Kalofonos, H;
    • Briassoulis, E;
    • Samantas, E
    Publication type:
    journal article
    14

    Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.

    Published in:
    PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163138
    By:
    • Kotoula, Vassiliki;
    • Lakis, Sotiris;
    • Vlachos, Ioannis S.;
    • Giannoulatou, Eleni;
    • Zagouri, Flora;
    • Alexopoulou, Zoi;
    • Gogas, Helen;
    • Pectasides, Dimitrios;
    • Aravantinos, Gerasimos;
    • Efstratiou, Ioannis;
    • Pentheroudakis, George;
    • Papadopoulou, Kyriaki;
    • Chatzopoulos, Kyriakos;
    • Papakostas, Pavlos;
    • Sotiropoulou, Maria;
    • Nicolaou, Irene;
    • Razis, Evangelia;
    • Psyrri, Amanda;
    • Kosmidis, Paris;
    • Papadimitriou, Christos
    Publication type:
    Article
    15

    Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.

    Published in:
    Breast Cancer Research & Treatment, 2005, v. 92, n. 1, p. 1, doi. 10.1007/s10549-005-0322-y
    By:
    • George Fountzilas;
    • Dimitrios Pectasides;
    • Anna Kalogera-Fountzila;
    • Dimosthenis Skarlos;
    • Haralambos P. Kalofonos;
    • Christos Papadimitriou;
    • Dimitrios Bafaloukos;
    • Stefanos Lambropoulos;
    • Savvas Papadopoulos;
    • Helen Kourea;
    • Christos Markopoulos;
    • Helen Linardou;
    • Dimitrios Mavroudis;
    • Evangelos Briasoulis;
    • Nicholaos Pavlidis;
    • Evangelia Razis;
    • Paraskevas Kosmidis;
    • Helen Gogas
    Publication type:
    Article
    16

    mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.

    Published in:
    Oncology Letters, 2022, v. 23, n. 1, p. N.PAG
    By:
    • Rapti, Vassiliki;
    • Moirogiorgou, Evangelia;
    • Koliou, Georgia-Angeliki;
    • Papadopoulou, Kyriaki;
    • Binas, Ioannis;
    • Pentheroudakis, George;
    • Bafaloukos, Dimitrios;
    • Bobos, Mattheos;
    • Chatzopoulos, Kyriakos;
    • Chrisafi, Sofia;
    • Christodoulou, Christos;
    • Nicolaou, Irene;
    • Sotiropoulou, Maria;
    • Magkou, Christina;
    • Koutras, Angelos;
    • Papakostas, Pavlos;
    • Kotsakis, Athanasios;
    • Razis, Evangelia;
    • Psyrri, Amanda;
    • Tryfonopoulos, Dimitrios
    Publication type:
    Article
    17
    18

    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

    Published in:
    PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0207707
    By:
    • Koutras, Angelos;
    • Lazaridis, Georgios;
    • Koliou, Georgia-Angeliki;
    • Kouvatseas, George;
    • Christodoulou, Christos;
    • Pectasides, Dimitrios;
    • Kotoula, Vassiliki;
    • Batistatou, Anna;
    • Bobos, Mattheos;
    • Tsolaki, Eleftheria;
    • Papadopoulou, Kyriaki;
    • Pentheroudakis, George;
    • Papakostas, Pavlos;
    • Pervana, Stavroula;
    • Petraki, Kalliopi;
    • Chrisafi, Sofia;
    • Razis, Evangelia;
    • Psyrri, Amanda;
    • Bafaloukos, Dimitrios;
    • Kalogeras, Konstantine T.
    Publication type:
    Article
    19
    20

    PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1289, doi. 10.1007/s00280-015-2762-3
    By:
    • Koumarianou, Anna;
    • Karayannopoulou, Georgia;
    • Gourgioti, Georgia;
    • Batistatou, Anna;
    • Bobos, Mattheos;
    • Efstratiou, Ioannis;
    • Miliaras, Dimosthenis;
    • Galani, Eleni;
    • Pentheroudakis, George;
    • Pectasides, Dimitrios;
    • Aravantinos, Gerasimos;
    • Bafaloukos, Dimitrios;
    • Papakostas, Pavlos;
    • Razis, Evangelia;
    • Kalofonos, Haralabos;
    • Petraki, Kalliopi;
    • Sotiropoulou, Maria;
    • Kalogeras, Konstantine;
    • Fountzilas, George
    Publication type:
    Article
    21
    22

    A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-111
    By:
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • Fountzilas, Elena;
    • Kouvatseas, George;
    • Basdanis, George;
    • Xanthakis, Ioannis;
    • Makatsoris, Thomas;
    • Charalambous, Elpida;
    • Papamichael, Demetris;
    • Samantas, Epaminontas;
    • Papakostas, Pavlos;
    • Bafaloukos, Dimitrios;
    • Razis, Evangelia;
    • Christodoulou, Christos;
    • Varthalitis, Ioannis;
    • Pavlidis, Nicholas;
    • Fountzilas, George
    Publication type:
    Article
    23

    A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

    Published in:
    2014
    By:
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • Fountzilas, Elena;
    • Kouvatseas, George;
    • Basdanis, George;
    • Xanthakis, Ioannis;
    • Makatsoris, Thomas;
    • Charalambous, Elpida;
    • Papamichael, Demetris;
    • Samantas, Epaminontas;
    • Papakostas, Pavlos;
    • Bafaloukos, Dimitrios;
    • Razis, Evangelia;
    • Christodoulou, Christos;
    • Varthalitis, Ioannis;
    • Pavlidis, Nicholas;
    • Fountzilas, George
    Publication type:
    journal article
    24

    Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-49
    By:
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • De Roock, Wendy;
    • Kouvatseas, George;
    • Papakostas, Pavlos;
    • Makatsoris, Thomas;
    • Papamichael, Demetris;
    • Xanthakis, Ioannis;
    • Sgouros, Joseph;
    • Televantou, Despina;
    • Kafiri, Georgia;
    • Tsamandas, Athanassios C.;
    • Razis, Evangelia;
    • Galani, Eleni;
    • Bafaloukos, Dimitrios;
    • Efstratiou, Ioannis;
    • Bompolaki, Iliada;
    • Pectasides, Dimitrios;
    • Pavlidis, Nicholas;
    • Tejpar, Sabine
    Publication type:
    Article
    25

    Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

    Published in:
    2013
    By:
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • De Roock, Wendy;
    • Kouvatseas, George;
    • Papakostas, Pavlos;
    • Makatsoris, Thomas;
    • Papamichael, Demetris;
    • Xanthakis, Ioannis;
    • Sgouros, Joseph;
    • Televantou, Despina;
    • Kafiri, Georgia;
    • Tsamandas, Athanassios C;
    • Razis, Evangelia;
    • Galani, Eleni;
    • Bafaloukos, Dimitrios;
    • Efstratiou, Ioannis;
    • Bompolaki, Iliada;
    • Pectasides, Dimitrios;
    • Pavlidis, Nicholas;
    • Tejpar, Sabine
    Publication type:
    journal article
    26

    Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study.

    Published in:
    BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-234
    By:
    • Razis, Evangelia;
    • Briasoulis, Evangelos;
    • Vrettou, Eleni;
    • Skarlos, Dimosthenis V.;
    • Papamichael, Dimitrios;
    • Kostopoulos, Ioannis;
    • Samantas, Epaminontas;
    • Xanthakis, Ioannis;
    • Bobos, Mattheos;
    • Galanidi, Eleni;
    • Bai, Eleni;
    • Gikonti, Ioanna;
    • Koukouma, Alona;
    • Kafiri, Georgia;
    • Papakostas, Pavlos;
    • Kalogeras, Konstantine T.;
    • Kosmidis, Paris;
    • Fountzilas, George
    Publication type:
    Article
    27

    A Tongue Lesion as a Sign of a Systemic Disease.

    Published in:
    Case Reports in Medicine, 2016, p. 1, doi. 10.1155/2016/6723575
    By:
    • Liakou, Chrysoula I.;
    • Koh, Joan;
    • Tsimpidakis, Antonios;
    • Rios, Katrina;
    • Paskalis, Charalabos;
    • Pipilis, Athanasios;
    • Kantianis, Dimitrios;
    • Georgiadis, Thomas;
    • Razis, Evangelia
    Publication type:
    Article
    28

    The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.

    Published in:
    2013
    By:
    • Strimpakos, Alexios;
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • De Roock, Wendy;
    • Kouvatseas, George;
    • Papakostas, Pavlos;
    • Makatsoris, Thomas;
    • Papamichael, Demetris;
    • Andreadou, Anna;
    • Sgouros, Joseph;
    • Zizi-Sermpetzoglou, Adamantia;
    • Kominea, Athina;
    • Televantou, Despina;
    • Razis, Evangelia;
    • Galani, Eleni;
    • Pectasides, Dimitrios;
    • Tejpar, Sabine;
    • Syrigos, Konstantinos;
    • Fountzilas, George
    Publication type:
    Journal Article
    29

    The Prognostic Role of Ephrin A2 and Endothelia Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab.

    Published in:
    Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 267, doi. 10.1016/j.clcc.2013.07.001
    By:
    • Strimpakos, Alexaos;
    • Pentheroudakis, George;
    • Kotoula, Vassiliki;
    • De Roock, Wendy;
    • Kouvatseas, George;
    • Papakostas, Pavlos;
    • Makatsoris, Thomas;
    • Papamichael, Demetris;
    • Andreadou, Anna;
    • Sgouros, Joseph;
    • Zizi-Sermpetzoglou, Adamantia;
    • Kominea, Athina;
    • Televantou, Despina;
    • Razis, Evangelia;
    • Galani, Eleni;
    • Pectasides, Dimitrios;
    • Tejpar, Sabine;
    • Syrigos, Konstantinos;
    • Fountzilas, George
    Publication type:
    Article
    30
    31

    Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients.

    Published in:
    Oral, 2023, v. 3, n. 1, p. 123, doi. 10.3390/oral3010011
    By:
    • Nicolatou-Galitis, Ourania;
    • Psyrri, Amanda;
    • Tsoukalas, Nikolaos;
    • Galitis, Evangelos;
    • Linardou, Helena;
    • Galiti, Dimitra;
    • Athansiadis, Ilias;
    • Kalapanida, Despoina;
    • Razis, Evangelia;
    • Katirtzoglou, Nikolaos;
    • Kentepozidis, Nikolaos;
    • Kosmidis, Paraskevas;
    • Stavridi, Flora;
    • Kyrodimos, Efthimios;
    • Daliani, Danai;
    • Tsironis, George;
    • Mountzios, Giannis;
    • Karageorgopoulou, Sofia;
    • Gouveris, Panagiotis;
    • Syrigos, Konstantinos
    Publication type:
    Article
    32

    The Role of CXCL13 and CXCL9 in Early Breast Cancer.

    Published in:
    2020
    By:
    • Razis, Evangelia;
    • Kalogeras, Konstantine T;
    • Kotsantis, Ioannis;
    • Koliou, Georgia-Angeliki;
    • Manousou, Kyriaki;
    • Wirtz, Ralph;
    • Veltrup, Elke;
    • Patsea, Helen;
    • Poulakaki, Nikiforita;
    • Dionysopoulos, Dimitrios;
    • Pervana, Stavroula;
    • Gogas, Helen;
    • Koutras, Angelos;
    • Pentheroudakis, George;
    • Christodoulou, Christos;
    • Linardou, Helena;
    • Pavlakis, Kitty;
    • Koletsa, Triantafyllia;
    • Pectasides, Dimitrios;
    • Zagouri, Flora
    Publication type:
    journal article
    33

    Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.

    Published in:
    2019
    By:
    • Kotoula, Vassiliki;
    • Tsakiri, Kalliopi;
    • Koliou, Georgia-Angeliki;
    • Lazaridis, Georgios;
    • Papadopoulou, Kyriaki;
    • Giannoulatou, Eleni;
    • Tikas, Ioannis;
    • Christodoulou, Christos;
    • Chatzopoulos, Kyriakos;
    • Bobos, Mattheos;
    • Pentheroudakis, George;
    • Tsolaki, Eleftheria;
    • Batistatou, Anna;
    • Kotsakis, Athanassios;
    • Koutras, Angelos;
    • Linardou, Helena;
    • Razis, Evangelia;
    • Res, Eleni;
    • Pectasides, Dimitrios;
    • Fountzilas, George
    Publication type:
    journal article
    34

    Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.

    Published in:
    2018
    By:
    • Batistatou, Anna;
    • Kotoula, Vassiliki;
    • Bobos, Mattheos;
    • Kouvatseas, George;
    • Zagouri, Flora;
    • Tsolaki, Eleftheria;
    • Gogas, Helen;
    • Koutras, Angelos;
    • Pentheroudakis, George;
    • Timotheadou, Eleni;
    • Pervana, Stavroula;
    • Goussia, Anna;
    • Petraki, Kalliopi;
    • Sotiropoulou, Maria;
    • Koletsa, Triantafyllia;
    • Razis, Evangelia;
    • Kosmidis, Paris;
    • Aravantinos, Gerasimos;
    • Papadimitriou, Christos;
    • Pectasides, Dimitrios
    Publication type:
    journal article
    35

    Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents.

    Published in:
    Oral Diseases, 2020, v. 26, n. 5, p. 955, doi. 10.1111/odi.13294
    By:
    • Nicolatou‐Galitis, Ourania;
    • Papadopoulou, Erofili;
    • Vardas, Emmanouil;
    • Kouri, Maria;
    • Galiti, Dimitra;
    • Galitis, Evangelos;
    • Alexiou, Konstantina‐Eleni;
    • Tsiklakis, Kostas;
    • Ardavanis, Alexandros;
    • Razis, Evangelia;
    • Athanasiadis, Ilias;
    • Droufakou, Stavroula;
    • Psyrri, Amanda;
    • Karamouzis, Michalis V.;
    • Linardou, Helena;
    • Daliani, Danai;
    • Tzanninis, Dimitrios;
    • Sachanas, Sotirios;
    • Laschos, Konstantinos;
    • Kyrtsonis, Marie‐Christine
    Publication type:
    Article
    36
    37

    Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial.

    Published in:
    PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069256
    By:
    • Fountzilas, George;
    • Kotoula, Vassiliki;
    • Pectasides, Dimitrios;
    • Kouvatseas, George;
    • Timotheadou, Eleni;
    • Bobos, Mattheos;
    • Mavropoulou, Xanthipi;
    • Papadimitriou, Christos;
    • Vrettou, Eleni;
    • Raptou, Georgia;
    • Koutras, Angelos;
    • Razis, Evangelia;
    • Bafaloukos, Dimitrios;
    • Samantas, Epaminontas;
    • Pentheroudakis, George;
    • Skarlos, Dimosthenis V.
    Publication type:
    Article
    38

    Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. 835, doi. 10.1002/onco.13855
    By:
    • Huang, Richard S.P.;
    • Haberberger, James;
    • McGregor, Kimberly;
    • Mata, Douglas A.;
    • Decker, Brennan;
    • Hiemenz, Matthew C.;
    • Lechpammer, Mirna;
    • Danziger, Natalie;
    • Schiavone, Kelsie;
    • Creeden, James;
    • Graf, Ryon P.;
    • Strowd, Roy;
    • Lesser, Glenn J.;
    • Razis, Evangelia D.;
    • Bartsch, Rupert;
    • Giannoudis, Athina;
    • Bhogal, Talvinder;
    • Lin, Nancy U.;
    • Pusztai, Lajos;
    • Ross, Jeffrey S.
    Publication type:
    Article
    39

    Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 107, n. 3, p. 431
    By:
    • Theodore Rampias;
    • George Koutsodontis;
    • Sophia Armaou;
    • Theodore Anagnostopoulos;
    • George Nikolopoulos;
    • Smaragda Kamakari;
    • George Nounesis;
    • Antonis Stylianakis;
    • Charisios Karanikiotis;
    • Evangelia Razis;
    • Helen Gogas;
    • Antonios Keramopoulos;
    • Vassiliki Gaki;
    • Christos Markopoulos;
    • Dimosthenis Skarlos;
    • Nikos Pandis;
    • Thalia Bei;
    • Iordanis Arzimanoglou;
    • Drakoulis Yannoukakos
    Publication type:
    Article
    40

    EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 737, doi. 10.1007/s00432-014-1626-2
    By:
    • Razis, Evangelia;
    • Pentheroudakis, George;
    • Rigakos, George;
    • Bobos, Mattheos;
    • Kouvatseas, George;
    • Tzaida, Olympia;
    • Makatsoris, Thomas;
    • Papakostas, Pavlos;
    • Bai, Maria;
    • Goussia, Anna;
    • Samantas, Epaminontas;
    • Papamichael, Demetrios;
    • Romanidou, Ourania;
    • Efstratiou, Ioannis;
    • Tsolaki, Eleftheria;
    • Psyrri, Amanda;
    • De Roock, Wendy;
    • Bafaloukos, Dimitrios;
    • Klouvas, George;
    • Tejpar, Sabine
    Publication type:
    Article
    41

    Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1435559
    By:
    • Smilkou, Stavroula;
    • Kaklamanis, Loukas;
    • Balgouranidou, Ioanna;
    • Linardou, Helena;
    • Papatheodoridi, Alkistis Maria;
    • Zagouri, Flora;
    • Razis, Evangelia;
    • Kakolyris, Stylianos;
    • Psyrri, Amanda;
    • Papadimitriou, Christos;
    • Markou, Athina;
    • Lianidou, Evi
    Publication type:
    Article
    42